Janus Henderson Group
ODT

Janus Henderson Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Janus Henderson Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,723,248
Closed -$52.3M – 1653
2020
Q4 		$52.3M Buy
2,723,248
+91,419
+3% +$1.41M 0.02% 518
2020
Q3 		$35.3M Buy
2,631,829
+974,750
+59% +$27.6M 0.02% 580
2020
Q2 		$70.2M Buy
1,657,079
+75,151
+5% +$2.43M 0.04% 403
2020
Q1 		$43.7M Buy
1,581,928
+252,440
+19% +$7.36M 0.03% 490
2019
Q4 		$43.1M Buy
1,329,488
+25,191
+2% +$781K 0.02% 636
2019
Q3 		$34M Sell
1,304,297
-11,129
-0.8% -$372K 0.02% 692
2019
Q2 		$48.3M Buy
1,315,426
+33,325
+3% +$799K 0.03% 584
2019
Q1 		$28.3M Sell
1,282,101
-21,105
-2% -$369K 0.02% 708
2018
Q4 		$18.3M Buy
1,303,206
+142,464
+12% +$2.22M 0.01% 773
2018
Q3 		$22.5M Buy
1,160,742
+86,394
+8% +$1.76M 0.01% 786
2018
Q2 		$23.7M Buy
1,074,348
+886,794
+473% +$20.7M 0.01% 759
2018
Q1 		$3.97M Sell
187,554
-2,675
-1% -$63.1K ﹤0.01% 1056
2017
Q4 		$4.76M Buy
+190,229
New +$4.49M ﹤0.01% 993

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Janus Henderson Group's ODT Position: Q1 2021 in Review

Janus Henderson Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 2,723,248 shares — an estimated $52.3M sold.

Janus Henderson Group first reported a position in ODT in Q4 2017 and held it in 13 quarters. The position peaked at $70.2M in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • Janus Henderson Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Janus Henderson Group sold 2,723,248 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $52.3M.
  • Janus Henderson Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2017 and held it in 13 quarters.
  • Janus Henderson Group's Odonate Therapeutics, Inc. Common Stock position peaked at $70.2M in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Janus Henderson Group's 13F filing for Q1 2021, filed 17 May 2021.